The commonest thing a metabolic clinic misses, because it presents as everything else on the list.
Obstructive sleep apnoea is the airway closing repeatedly during sleep, each time interrupting breathing until the brain partially wakes to reopen it. It can happen dozens of times an hour, every hour, for years, and the person often has no memory of any of it.
It travels with the same risk factors as metabolic disease — central weight, male sex, age, neck circumference — and large epidemiological studies have found a substantial proportion of cases undiagnosed. Which means a clinic treating fatigue and stalled weight is, statistically, going to see it regularly without looking for it.
The relationship runs in both directions, and that is what makes it easy to miss.
Weight drives apnoea. Fat around the neck and pharynx narrows the airway; fat around the abdomen reduces lung volume, which makes the airway more collapsible.
Apnoea appears to drive metabolic trouble. The repeated drops in oxygen and the fragmented sleep are associated with insulin resistance and raised glucose, in studies that adjust for body weight. The proposed mechanisms are sympathetic nervous system activation, cortisol disturbance and inflammation.
Each worsens the other, which is why it is described as a cycle rather than a complication.
Almost always as something else:
Read that list beside the symptoms attributed to low testosterone, or to hypothyroidism, or to "just getting older". They are the same list. That overlap is the entire problem.
Worth isolating, because it produces real harm.
Untreated sleep apnoea lowers testosterone, through disrupted sleep architecture. So a man with apnoea presents with fatigue, low libido and a genuinely low testosterone result.
If testosterone is prescribed without the apnoea being found, two things follow. The cause is untreated. And testosterone therapy can worsen apnoea in some men, as well as raising haematocrit — which in someone with nocturnal oxygen drops is a combination worth avoiding.
This is a concrete reason why a clinic should ask about sleep before writing a hormone prescription, and a fair question to ask of any clinic that does not.
Not by a blood test, and not by a smartwatch. A watch or ring that reports "sleep quality" or estimates apnoea is a consumer device, not a diagnostic one, and a reassuring reading from it means little.
Both are available privately in Costa Rica. Neither is something a longevity clinic performs itself, and a clinic that tells you it has ruled apnoea out without a study has not.
CPAP — continuous positive airway pressure — holds the airway open and is the main treatment. It improves sleepiness and quality of life consistently.
On metabolic markers the evidence is more mixed than often presented: several trials have found modest or inconsistent effects on glucose and weight. Mandibular advancement devices help selected people with milder disease. Weight loss improves apnoea, which is where the two problems meet.
Nothing here diagnoses anything. If the symptom list above describes you — particularly if someone has told you that you stop breathing — that is a reason to ask about a sleep study, before accepting any explanation that begins with a hormone.
Every patient starts the same way: thirty minutes with a physician, then a full biomarker panel drawn at a laboratory near you. Whether any medicine follows is your doctor’s decision, made after reading your results with you.
Measure my biomarkers